Page 2 - இந்த் ஸ்விஃப்ட் ஆய்வகங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rs 5 to Rs 120: This stock has turned into a multibagger in one year An investment of Rs 1 lakh in the share a year ago would have grown to Rs 21.86 lakh today Aseem Thapliyal | March 8, 2021 | Updated 19:03 IST Bafna Pharma stock has outperformed its peers in terms of returns during the last one year. Against 2,086% rise in Bafna Pharma share, share of Venus Remedies could climb 689%. Share of Bafna Pharma has delivered strong returns to investors in last one year. Bafna Pharma share price stood at Rs 5.51 an year ago and closed at Rs 120.50 March 8, translating into gains of 2,086.93% during the period. In comparison, Sensex gained 34.24% during the period.

Themis biosynBafna pharmaVenus remediesGujarat themis biosynInd swift labsShare of bafna pharmaBafna pharma investorsBafna pharma share price risesVenus remedies shareGujarat themis biosyn shareBafna pharma net profitBafna pharma stockபாஃப்னா பார்மாவெள்ளி வைத்தியம்இந்த் ஸ்விஃப்ட் ஆய்வகங்கள்பகிர் ஆஃப் பாஃப்னா பார்மா